198 related articles for article (PubMed ID: 25956189)
21. Systematic screening and assessment of psychosocial well-being and care needs of people with cancer.
Schouten B; Avau B; Bekkering GTE; Vankrunkelsven P; Mebis J; Hellings J; Van Hecke A
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012387. PubMed ID: 30909317
[TBL] [Abstract][Full Text] [Related]
22. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
[TBL] [Abstract][Full Text] [Related]
23. Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review.
Rutherford C; Patel MI; Tait MA; Smith DP; Costa DSJ; King MT
Support Care Cancer; 2018 Apr; 26(4):1061-1076. PubMed ID: 29392479
[TBL] [Abstract][Full Text] [Related]
24. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
25. Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.
Brundage M; Blazeby J; Revicki D; Bass B; de Vet H; Duffy H; Efficace F; King M; Lam CL; Moher D; Scott J; Sloan J; Snyder C; Yount S; Calvert M
Qual Life Res; 2013 Aug; 22(6):1161-75. PubMed ID: 22987144
[TBL] [Abstract][Full Text] [Related]
26. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
[TBL] [Abstract][Full Text] [Related]
27. A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice.
Mercieca-Bebber R; Friedlander M; Calvert M; Stockler M; Kyte D; Kok PS; King MT
J Patient Rep Outcomes; 2017; 1(1):5. PubMed ID: 29757300
[TBL] [Abstract][Full Text] [Related]
28. A conceptual framework for patient-reported outcomes in non-muscle invasive bladder cancer.
Rutherford C; Costa DSJ; King MT; Smith DP; Patel MI
Support Care Cancer; 2017 Oct; 25(10):3095-3102. PubMed ID: 28451912
[TBL] [Abstract][Full Text] [Related]
29. The level of reporting of neurocognitive outcomes in randomised controlled trials of brain tumour patients: A systematic review.
Habets EJJ; Taphoorn MJB; Klein M; Vissers T; Dirven L
Eur J Cancer; 2018 Sep; 100():104-125. PubMed ID: 30014880
[TBL] [Abstract][Full Text] [Related]
30. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Iannizzi C; Chai KL; Valk SJ; Kimber C; Dorando E; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013600. PubMed ID: 34013969
[TBL] [Abstract][Full Text] [Related]
31. Underreporting of patient-reported outcomes in cystic fibrosis randomized controlled trials using CONSORT-PRO and RoB 2.0.
Moore T; Nees D; Hightower B; Brock L; Kee M; Wise A; Heigle B; Ottwell R; Hartwell M; Vassar M
Respir Med Res; 2023 Jun; 83():100962. PubMed ID: 36563550
[TBL] [Abstract][Full Text] [Related]
32. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
[TBL] [Abstract][Full Text] [Related]
33. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
Pe M; Dorme L; Coens C; Basch E; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dirven L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Griebsch I; Groenvold M; King M; Koller M; Malone DC; Martinelli F; Mitchell SA; Musoro JZ; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Sloan J; Velikova G; Bottomley A;
Lancet Oncol; 2018 Sep; 19(9):e459-e469. PubMed ID: 30191850
[TBL] [Abstract][Full Text] [Related]
34. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.
Matza LS; Patrick DL; Riley AW; Alexander JJ; Rajmil L; Pleil AM; Bullinger M
Value Health; 2013 Jun; 16(4):461-79. PubMed ID: 23796280
[TBL] [Abstract][Full Text] [Related]
35. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy.
Bylicki O; Gan HK; Joly F; Maillet D; You B; Péron J
Ann Oncol; 2015 Jan; 26(1):231-237. PubMed ID: 25355720
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
MacLehose RR; Reeves BC; Harvey IM; Sheldon TA; Russell IT; Black AM
Health Technol Assess; 2000; 4(34):1-154. PubMed ID: 11134917
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
38. Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G).
Smith AB; Cocks K; Parry D; Taylor M
Qual Life Res; 2014 Apr; 23(3):971-6. PubMed ID: 24097080
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
